Adaptimmune

Our fight with cancer is personal.

Arming cells. Against cancer. For good.

Announcement of Sale of TECELRA, lete-cel, afami-cel & uza-cel Cell Therapies to US WorldMeds

< >

The time is now to redefine how cancer is treated.

About Us

Redefining the treatment of solid tumor cancers.

Adaptimmune is committed to treating the most challenging solid tumors using a proprietary cell therapy platform that harnesses a patient's cells to combat their cancer.

Using a personalized approach that has the potential to radically improve the patient experience.

We use cell therapy, a promising yet complex area of science, to engineer a person’s own cells to fight cancer.

A future where a single infusion could potentially reshape cancer care.

We are a fully integrated company on the verge of a new era.